Tevogen Inc. (TVGNW)
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.
Sector: Biological Products, (No Diagnostic Substances)
Tevogen Inc.
NASDAQ:TVGNWSub-class of TVGN
-2.64%$0.0847
CLOSED · Nov 6Prev close$0.0870-2.64%Close$0.0847+3.90%AH close$0.0880
AH$0.0880+3.90%vs close
Mkt Cap$5.75M
Float43.58M
O/S67.88M
VOL759K sh
$ Vol$62K
RVOL1.50×
Inst Own-
SI0.2%
EarningsNov 13 · in 4d
Dilution